Nick Tait
Direttore Finanziario/CFO presso Metrion Biosciences Ltd.
Profilo
Nick Tait is the founder of The Great Little Pub Co. Ltd.
He is currently working as the Chief Financial Officer, Secretary & Director at Metrion Biosciences Ltd.
Posizioni attive di Nick Tait
| Società | Posizione | Inizio |
|---|---|---|
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Nick Tait
| Società | Posizione | Fine |
|---|---|---|
The Great Little Pub Co. Ltd.
 The Great Little Pub Co. Ltd. RestaurantsConsumer Services The Great Little Pub Co. Ltd. owns and operates pubs and restaurants. The company was founded by Nick Tait and is headquartered in Brighton, the United Kingdom. | Fondatore | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
The Great Little Pub Co. Ltd.
The Great Little Pub Co. Ltd. RestaurantsConsumer Services The Great Little Pub Co. Ltd. owns and operates pubs and restaurants. The company was founded by Nick Tait and is headquartered in Brighton, the United Kingdom. | Consumer Services |
Metrion Biosciences Ltd.
Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Health Technology |
- Borsa valori
- Insiders
- Nick Tait
